I am a molecular pathologist and gynecologic pathologist at the Department of Laboratory Medicine and Pathology. My research is focused on advancing Precision Medicine in the gynecologic tract cancers, including ovarian and uterine cancers. My goal is to incorporate molecular diagnostics and image analysis (artificial intelligence) into the early detection, diagnosis (classification), prognosis, clinical management and monitoring of these cancers by translating the scientific knowledge into clinical tests. I am particularly interested in developing innovative molecular and tissue imaging biomarkers for gynecologic borderline tumors to increase the diagnostic accuracy, predict their biologic behaviors and guide the treatment strategy.

Brooke E. Howitt, MD, is an Associate Professor in the Pathology Department at Stanford University. She received a BA in Biology from Washington University in St. Louis and then obtained her medical degree from Stanford University. Dr. Howitt then completed an Anatomic Pathology residency and the Women's and Perinatal Pathology Fellowship at Brigham and Women's Hospital where she stayed on as faculty. Dr. Howitt joined Stanford in 2017. She has co-authored over 100 peer-reviewed articles and numerous book chapters. Dr. Howitt is on editorial boards for Modern Pathology, International Journal of Gynecologic Pathology, and Human Pathology. Her research interests focus on gynecologic neoplasms and their precursor lesions, aiming to better understand morphologic and molecular alterations associated with clinical relevance.

Outside of work, Dr. Howitt enjoys running, hiking, and exploring the outdoors with her two sons.

Dr. Lee is a surgical pathologist at the Royal Alexandra Hospital and University of Alberta in Edmonton (Canada) and has a diagnostic and research focus on gynecologic pathology/oncology.

Dr. Martin Koebel is a clinician scientist and gynecological pathologist. He received his medical degree from the Friedrich Schiller University in Jena, Germany and did his pathology residency at the Charite hospital, Berlin, Germany. Since 2009 he is faculty at the University of Calgary now at the rank of Associate Professor in the Department of Pathology and Laboratory Medicine.

He has authored 230 scientific articles in the field of ovarian and endometrial carcinomas and supervised 5 fellows and 1 PhD student. He is participating in national and international research consortia such as the TFRI-funded Canadian Ovarian Experimental Unified Resource (COEUR) and the Ovarian Tumor Tissue Analysis (OTTA) consortium.

Dr. Lee is a gynecologic pathologist from Calgary. She completed her fellowship in Gynecologic Pathology in 2014 at the University of Calgary following residency training in Anatomical Pathology at the University of Calgary. She is currently working at the South Health Campus in Calgary, Alberta.

Associate Professor Department of Pathology and Laboratory Medicine University of Calgary, Alberta Precision Laboratories.

Graduate of the University of Calgary Anatomic Pathology Residency program with subsequent fellowships in molecular pathology at the University of Toronto, Mount Sinai Hospital and at the University of Calgary, Calgary Laboratory Services. Member of the Breast and Gynecologic Pathology Tumor Boards at the Tom Baker Cancer Centre

Joe Rabban MD MPH is Professor and head of the gynecologic pathology service at University of California San Francisco, where he is also director of the gynecological pathology fellowship. He graduated from Harvard Medical School and Harvard School of Public Health, followed by anatomic pathology residency training at UCSF, as well as combined gynecological and breast pathology fellowship at Massachusetts General Hospital. He is an editor and author of the 5th edition WHO Classification of Female Genital Tumors and an author of several cancer reporting guidelines from the International Society of Gynecological Pathologists and International Collaboration on Cancer Reporting. He is an associate editor of the International Journal of Gynecological Pathology and member of the American Board of Pathology test development and advisory committee. His research focuses on tumor classification and pathology of hereditary tumor syndromes. He enjoys cooking, art history, and road cycling.

Dr. Robert Soslow is Professor of Pathology at the Cleveland Clinic Lerner College of Medicine staring August 1, 2023.

With more than 400 publications, Dr. Soslow is one of the foremost authorities on gynecologic malignancies. Recent research interests include cervical carcinomas, uterine mesenchymal tumors, hereditary gynecologic cancer syndromes and genotype-phenotype correlations. He is an award-winning teacher and mentor to junior attending staff and trainees. He was an editorial board member for 2020 WHO blue book and co-authored the AFIP/ARP fascicle for Tumors of the Uterine Corpus (fourth series) and the upcoming AFIP/ARP fascicle for Ovarian Tumors (fifth series). On a more personal note, Dr. Soslow enjoys traveling, reading, photography, collecting banknotes, learning foreign languages, figure skating and Pilates.

Dr Brundler is a senior pediatric and perinatal pathologist. In the past 10 years, placental pathology has been a focus of her clinical practice and research which includes local and national collaborations. She is a co-author of the widely cited

Amstersdam consensus paper and a textbook on placental pathology. Outside work, she loves to spend time with her noodle horse and horseback riding.

Katharina Wiedemeyer, MD

Dermatologist and Dermatopathologist from Germany

Currently Anatomical Pathology Resident at the University of Calgary

Fields of Interest:

Clinicopathological characterization of skin adnexal tumors and melanocytic skin tumors.

Zainab Mohammed Al-Shamma

Medical school at the College of Medicine/ University of Baghdad

Training in Anatomical Pathology in Baghdad and I am a Fellow of the Iraqi Board of Medical

Specialization

Training in Anatomical Pathology at the University of Alberta

Gynecological Pathology Fellowship at the University of Calgary

Currently, Clinical assistant professor at the University of Calgary/ Cumming School of Medicine and a staff Pathologist at the Foothills medical center

After obtaining her medical degree at the University of Ottawa, Dr Sabourin completed her Obstetrics and Gynecology Residency at the University of Alberta, followed by a Fellowship in Gynecologic Oncology at the University of Calgary. During fellowship, she completed a Master of Public Health at the Johns Hopkins University Bloomberg School of Public Health. Dr Sabourin has worked as a Gynecologic Oncologist and Colposcopist at the Cross Cancer Institute and Royal Alexandra Hospital in Edmonton since 2015 and is a Clinical Assistant Professor in the University of Alberta Obstetrics and Gynecology Department.